Results
|
|
1.
|
A prospective, multicentre first-in-man study of the polymer-free ultrathin-strut BIOrapid stent (BIOVITESSE). MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2022
Citation: - Eurointervention. 18(2):e132-e139, 2022 Jun 03.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
All authors: - Garcia-Garcia HM, Haner JD, Luscher TF, Moccetti M, Muller O, Raber L, Roffi M, Siegrist P, Stortecky S, Waksman R
|
|
|
2.
|
Comparison of the Ultrathin Strut, Biodegradable Polymer Sirolimus-eluting Stent With a Durable Polymer Everolimus-eluting Stent in a Chinese Population: The Randomized BIOFLOW VI Trial. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2020
Citation: - Clinical Therapeutics. 42(4):649-660.e9, 2020 04.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - BIOFLOW VI Trial Investigators, Gao R, Garcia-Garcia HM, Guan C, Han Y, Li C, Song D, Waksman R, Xu B, Xu J, Yang Y
|
|
|
3.
|
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2017
Citation: - Lancet. 390(10105):1843-1852, 2017 Oct 21.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Massaro JM, Mauri L, Roguin A, Waksman R
|
|
|
4.
|
Efficacy and Safety of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin, Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization of Patients With Diabetes Mellitus. MedStar authors:
- Kolm, Paul
- Lipinski, Michael J
- Shlofmitz, Evan
- Torguson, Rebecca
- Waksman, Ron
Year: 2019
Citation: - American Journal of Cardiology. 124(7):1020-1026, 2019 10 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Kandzari D, Kolm P, Koolen JJ, Lipinski MJ, Saito S, Shlofmitz E, Torguson R, Waksman R, Windecker S
|
|
|
5.
|
Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial. MedStar authors:
Year: 2015
Citation: - Circulation: Cardiovascular Interventions. 8(2):e001441, 2015 Feb.
Institution: - MedStar Heart & Vascular Institute
All authors: - Barragan P, Bilger J, Cook S, Erne P, Goicolea J, Haude M, Juni P, Lefevre T, Merkely B, Neumann FJ, Piot C, Richardt G, Sabate M, Schneider H, Slagboom T, Stangl K, Waksman R, Windecker S, Witzenbichler B, Zaugg S
|
|
|
6.
|
Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2018
Citation: - Circulation: Cardiovascular Interventions. 11(10):e007331, 2018 Oct.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Marcusohn E, Massaro JM, Roguin A, Waksman R
|
